Gavin Conferences invites participants from all over the world to attend “International Conference on Diabetes and Endocrinology Disorders”. Diabetes 2017 is a three day conference going to be held during May 15-17, 2017 at Dubai, UAE and is open to attendees, academics and non-academic audiences.The three day conference is designed to bring researchers, academicians, doctorates, professors, lecturers and scholars to discuss research and share ideas regarding career interests to make event experience even better. During the event, participants can build networks and share information and ideas with one another.The World Diabetes Foundation estimates that there will be 438 million people with diabetes by the year 2030. It advances our understanding of trends in diabetes prevalence, of the contribution of high blood glucose to premature mortality, and of what action governments are taking to prevent and control diabetes.
Our aim is to increase global awareness of Diabetes risks and illuminate consciousness of endocrinology disorders.
The Global Diabetes market featuring insulin products is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment is established with an investment of $13.5 billion. Global Market for Diabetes Therapies & Diagnostics is to be worth $51.2 billion in 2015. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 per cent. GBI Research's analysis shows that the overall global endocrinology market was valued at $6.0 billion in 2010. It grew from $4.0 billion in 2004 at a CAGR of 6.9%. The market is expected to witness comparatively moderate